Therapeutic Advances in Urology is a distinguished, peer-reviewed journal published by SAGE Publications Ltd, dedicated to disseminating groundbreaking research and advancements in the field of urology. With an impressive impact factor and classified in the Q2 category for Urology as of 2023, this journal plays a critical role in advancing knowledge and clinical practices related to urological diseases and therapies. Since its establishment in 2009, the journal has transitioned to an Open Access format as of 2019, ensuring that vital research findings are freely available to researchers, healthcare professionals, and students worldwide. The journal is ranked #44 out of 120 in the Medicine - Urology category within Scopus, reflecting its commitment to high-quality, impactful scholarship. Whether you are seeking to keep abreast of the latest therapeutic innovations or contribute to the evolving discourse in urology, Therapeutic Advances in Urology is an essential resource for those passionate about improving patient outcomes and advancing clinical practices.

UROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.

EUROPEAN UROLOGY is a prestigious journal in the field of urology, published by Elsevier, and residing in the vibrant academic landscape of the Netherlands. Since its inception in 1975, the journal has made significant contributions to urological research, earning a top rank of #1 out of 120 in the Scopus category of Medicine - Urology, placing it within the esteemed 99th percentile of its field. With a commitment to disseminating cutting-edge research, clinical findings, and innovative practices, EUROPEAN UROLOGY has established itself as a pivotal resource for urologists and researchers alike. Although it does not offer open access options, it provides an indispensable platform for scholarly communication that drives advancements in patient care and medical knowledge. As the journal embarks on converged years leading up to 2024, it continues to strive for excellence in urology, welcoming contributions that reflect the latest scientific advancements and clinical applications.

European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.

PROGRES EN UROLOGIE is a renowned academic journal published by Elsevier Masson, Corp Off that focuses on the dynamic field of urology. With an ISSN of 1166-7087 and an E-ISSN of 2405-5131, this journal has been contributing to the scientific community since its inception in 1991 and continues to disseminate valuable research findings to urologists and medical professionals. As of 2023, it holds a distinguished position within the Q3 category in Urology, reflecting its commitment to publishing high-quality and impactful research—ranked 74th out of 120 in the Scopus Urology category, placing it in the 38th percentile. While it does not currently offer open access options, the journal remains an essential resource for researchers seeking to advance their understanding of the latest urological practices and innovations. Its contributions are vital in a rapidly evolving medical landscape, ensuring that both established and emerging issues in urology are thoroughly explored and discussed.

Urology Research and Practice, published by AVES in Turkey, is an essential open-access journal dedicated to advancing the field of urology. With its inaugural issues released in 2023, the journal aims to disseminate cutting-edge research, innovative practices, and insightful clinical studies pertinent to urology, thereby fostering knowledge and collaboration among researchers, healthcare professionals, and students alike. Currently indexed in Scopus, it ranks Q3 in the urology category, reflecting its growing impact evidenced by a 47th percentile ranking in the Medicine Urology field. The journal not only serves as a platform for exceptional scholarly work but also emphasizes accessibility and inclusivity in scientific communication, allowing for a broader dissemination of urological knowledge globally. Explore groundbreaking research and contribute to the evolving landscape of urology through Urology Research and Practice.

Urological Science, published by Lippincott Williams & Wilkins, is a prominent open-access journal that has been a vital resource for the Urology field since its establishment in 2010. With a focus on innovative research and advancements in urological science, the journal aims to disseminate significant findings and encourage dialogue among physicians, researchers, and healthcare professionals worldwide. The journal has achieved a commendable Q3 rank within its category according to the latest quartiles released in 2023 and holds a Scopus rank of #80 out of 120 in the Medicine Urology field, placing it in the 33rd percentile. By providing an open-access platform, Urological Science ensures that vital research is easily accessible to a global audience, supporting the ongoing advancements in urological healthcare and education. As the landscape of urology evolves, this journal remains an essential vehicle for sharing knowledge and improving patient outcomes, making it an invaluable resource for anyone invested in the future of urological science.

BJU International is a prestigious academic journal specializing in the field of Urology, published by WILEY, one of the leading publishers in scientific literature. With an impressive impact factor and recognized as a Q1 journal in Urology for 2023, it ranks #7 out of 120 in the Scopus Medicine _ Urology category, placing it in the 94th percentile among its peers. Established in 1929 and with converged years from 1994 to 2024, BJU International provides a platform for groundbreaking research, clinical studies, and advancements in urological science. The journal is accessible in both print and online formats, catering to a global audience dedicated to enhancing urological practice and research. By fostering interdisciplinary dialogue and disseminating high-quality studies, BJU International plays a crucial role in advancing knowledge and improving patient care in the field of urology.

BMC Urology is a premier open-access journal dedicated to advancing research in the field of urology, reproductive medicine, and miscellaneous aspects of medicine. Published by BMC since 2001 and based in the United Kingdom, this journal provides a platform for researchers, clinicians, and students to disseminate their findings and explore the latest innovations and advancements within these vital fields. With a notable impact factor and categorization in the Q2 quartile for various categories of medicine, BMC Urology stands as a reputable source, ranking 51st out of 120 in Urology and 44th out of 90 in Reproductive Medicine according to Scopus metrics. The journal fosters knowledge sharing through its open-access model, ensuring that research is accessible to all. As it converges from 2001 to 2024, BMC Urology continues to play a crucial role in shaping the landscape of urological research and providing invaluable insights into clinical practices.

European Urology Focus is a premier journal published by Elsevier, dedicated to advancing the field of urology. With its inception dating back to 2015 and a convergence period extending through 2024, this journal has rapidly established itself as a leading platform within the medical community, boasting an impressive Scopus ranking of #5 out of 120 in Urology, placing it in the 96th percentile. The journal is recognized for its impactful contributions to urological research, and it is classified in the prestigious Q1 category for Urology in 2023. Based in the Netherlands, European Urology Focus prioritizes innovative research, reviews, and clinical observations, catering not only to seasoned professionals but also to emerging scholars and practitioners in the field. While traditionally a subscription-based journal, it offers flexible access options tailored for its diverse readership. With a commitment to enhancing knowledge and improving patient outcomes in urological health, European Urology Focus stands as a vital resource for those engaged in this essential area of medicine.